Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LENZ (lenzilumab)
i
Other names:
KB003, KB-003, KB 003
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Humanigen, Telcon
Drug class:
GM-CSF inhibitor
‹
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
NRAS mutation
Chronic Myelomonocytic Leukemia
NRAS mutation
Chronic Myelomonocytic Leukemia
lenzilumab
Sensitive: C2 – Inclusion Criteria
lenzilumab
Sensitive
:
C2
lenzilumab
Sensitive: C2 – Inclusion Criteria
lenzilumab
Sensitive
:
C2
CBL mutation
Chronic Myelomonocytic Leukemia
CBL mutation
Chronic Myelomonocytic Leukemia
lenzilumab
Sensitive: C2 – Inclusion Criteria
lenzilumab
Sensitive
:
C2
lenzilumab
Sensitive: C2 – Inclusion Criteria
lenzilumab
Sensitive
:
C2
KRAS mutation
Chronic Myelomonocytic Leukemia
KRAS mutation
Chronic Myelomonocytic Leukemia
lenzilumab
Sensitive: C2 – Inclusion Criteria
lenzilumab
Sensitive
:
C2
lenzilumab
Sensitive: C2 – Inclusion Criteria
lenzilumab
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login